Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03217095
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O34 | 0.7 | |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O31 | 0.7 | |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O33 | 0.7 | |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O32 | 0.7 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEF | 0.75 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEG | 0.75 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,T | 2JEI | 0.75 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEJ | 0.75 | |
207 | 1-AMINO-6-CYCLOHEX-3-ENYLMETHYLOXYPURINE | A | 1H0W | 0.77 | |
DOT | 3'ANTHRANILOYL-2'-DEOXY-ADENOSINE- 5'-TRIPHOSPHATE | A,B,C,D,E,F | 1LVC | 0.72 | |
5OB | 5-METHOXYBENZIMIDAZOLE | A | 1JHP | 0.73 | |
MBZ | 1-[2-DEOXYRIBOFURANOSYL]-4-METHYL- BENZOIMIDAZOLE-5'-MONOPHOSPHATE | 1,2 | 1EEK | 0.72 | |
PUY | PUROMYCIN | A,B | 2DPT | 0.74 | |
PUY | PUROMYCIN | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q7Y | 0.74 | |
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CET | 0.72 | |
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CER | 0.72 | |
H35 | N-(FURAN-2-YLMETHYL)-7H-PURIN-6- AMINE | A | 2UY5 | 0.71 | |
HDY | 1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2- A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN- 2-OL | A | 1OIR | 0.75 | |
IMK | 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL- 1-BENZIMIDAZOLE | A | 1XKX | 0.79 | |
UA2 | 3,4-PYRROLIDINEDIOL,2-(4-AMINO- 5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)- 5-(HYDROXYMETHYL)-2S,3S,4R,5R | A,B,C | 2I4T | 0.83 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 5 | 1NJP | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,2,3,4,5, 9,A,B,C,D,F, H,J,K,L,M,N, O,Q,R,S,T,U, Y,Z | 1VQN | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,D,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQO | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,5 | 1NJM | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 5 | 1NJO | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,D,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQL | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,2,3,4,9, A,B,C,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQM | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q82 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,2,4,9,A,B, C,H,I,J,K,L, M,N,P,Q,R,S, T,X,Y,Z | 1KQS | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | B | 1FG0 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q81 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,F,H,J,K, L,M,N,O,Q,R, S,T,U,Y,Z | 3CD6 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,D,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQP | 0.72 | |
ABS | (S)-(N-PHENYL-2-HYDROXY-ETHYL)- 2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE | A | 1K5F | 0.79 | |
FM2 | 2-(7-AMINO-6-METHYL-3H-PYRAZOLO[4,3- D]PYRIMIDIN-3-YL)-5-HYDROXYMETHYL- TETRAHYDRO-FURAN-3,4-DIOL | A,B,C,D,E,F | 1K9S | 0.84 | |
RFZ | 5,6-dichloro-1-beta-D-ribofuranosyl- 1H-benzimidazole | A,B | 3H30 | 0.73 | |
DF9 | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2- d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin- 3-ol | A,B | 3DF9 | 0.7 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 2OC9 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 1B8O | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B,C | 1G2O | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B,C,D,E,F | 1NW4 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 1RT9 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B | 2FF1 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B | 2FF2 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 2OC4 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | E | 2Q7O | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 1RR6 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B | 3B9G | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | E | 1PF7 | 0.8 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 2ON6 | 0.8 | |
TDI | (3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN- 3-OL | A,B | 1Y6Q | 0.7 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 2QUJ | 0.73 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6K | 0.73 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 1R6U | 0.73 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6M | 0.73 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 1R6T | 0.73 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6L | 0.73 | |
3FD | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- [(3,4-dichlorophenyl)methylamino]purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZL | 0.73 | |
2A6 | 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE | A,C | 1H1Q | 0.72 | |
IHI | 9-CYCLOPENTYL-6-[2-(3-IMIDAZOL- 1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE- 2-CARBONITRILE | A | 1U9W | 0.72 | |
1BM | 3-{[2-(1H-BENZIMIDAZOL-1-YL)-6- {[2-(DIETHYLAMINO)ETHYL]AMINO}PYRIMIDIN- 4-YL]AMINO}-4-METHYLPHENOL | A | 2HK5 | 0.71 | |
3BK | (2R,3R,4S,5R)-2-[6-amino-8-[(3,4- dichlorophenyl)methylamino]purin- 9-yl]-5-(hydroxymethyl)oxolane- 3,4-diol | A | 3FZK | 0.72 | |
NXX | A,B,C,D | 3DLA | 0.71 | ||
NXX | A,B,C | 2QTR | 0.71 | ||
TYA | A | 3TS1 | 0.75 | ||
YMP | O-(ADENOSINE-5'-O-YL)-N-(L-TYROSYL)PHOSPHORAMIDATE | X,Y | 2DLC | 0.71 | |
1DA | 1-DEAZA-ADENOSINE | A | 1ADD | 0.82 | |
ALH | 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE | A,B | 1UNG | 0.73 | |
NVG | 4-AMINO-1-(5-{[3-(1H-BENZIMIDAZOL- 2-YL)PROPANOYL]AMINO}-5-DEOXY-ALPHA- L-LYXOFURANOSYL)PYRIMIDIN-2(1H)- ONE | A,B | 2V2Q | 0.74 | |
1RB | 1-ALPHA-D-RIBOFURANOSYL-BENZIMIAZOLE- 5'-PHOSPHATE | A | 1L5K | 0.76 | |
CK9 | 2-{[(2-{[(1R)-1-(HYDROXYMETHYL)PROPYL]AMINO}- 9-ISOPROPYL-9H-PURIN-6-YL)AMINO]METHYL}PHENOL | X | 2A0C | 0.71 | |
DBI | PHOSPHORIC ACID MONO-[5-(5,6-DIMETHYL- BENZOIMIDAZOL-1-YL)-4-HYDROXY-2- HYDROXYMETHYL-TETRAHYDRO-FURAN- 3-YL] ESTER | A | 1ID8 | 0.73 | |
MNT | 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE- 5'-DIPHOSPHATE | A | 1LVK | 0.72 | |
R6C | (2R)-2-{[6-(BENZYLOXY)-9-ISOPROPYL- 9H-PURIN-2-YL]AMINO}BUTAN-1-OL | A | 1YHJ | 0.71 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1X38 | 0.73 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1LQ2 | 0.73 | |
FMC | FORMYCIN | A,B | 2QTT | 0.86 | |
FMC | FORMYCIN | A | 1MRH | 0.86 | |
FMC | FORMYCIN | A | 1SD1 | 0.86 | |
FMC | FORMYCIN | A | 1MRK | 0.86 | |
FMC | FORMYCIN | A,B | 1NC3 | 0.86 | |
FMC | FORMYCIN | A | 1Z36 | 0.86 | |
FMC | FORMYCIN | A | 3BL6 | 0.86 | |
FMC | FORMYCIN | A | 1IFU | 0.86 | |
PMO | N1-(5'-PHOSPHO-ALPHA-RIBOSYL)-5- METHOXYBENZIMIDAZOLE | A | 1JHQ | 0.75 | |
IHJ | 9-CYCLOPENTYL-6-{2-[3-(4-METHYL- PIPERAZIN-1-YL)-PROPOXY]-PHENYLAMINO}- 9H-PURINE-2-CARBONITRILE | A | 1U9X | 0.71 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A | 2BGM | 0.7 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1N8K | 0.7 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A | 2BGL | 0.7 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1N92 | 0.7 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1H2B | 0.7 | |
TAP | 7-THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | A | 1DR2 | 0.73 | |
TAP | 7-THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | A | 1DR3 | 0.73 | |
TAP | 7-THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | A,B | 1PT9 | 0.73 | |
ZZB | A | 2WFG | 0.76 | ||
AD5 | N~6~-cyclohexyl-N~2~-(4-morpholin- 4-ylphenyl)-9H-purine-2,6-diamine | A,B | 2VGO | 0.7 | |
NBS | A | 1KSW | 0.74 | ||
AD3 | 3-DEAZA-ADENOSINE | A,B | 1KIE | 0.82 | |
AD3 | 3-DEAZA-ADENOSINE | A,B,C,D | 2ZIZ | 0.82 | |
AD3 | 3-DEAZA-ADENOSINE | A,B | 1R4F | 0.82 | |
AD3 | 3-DEAZA-ADENOSINE | A,B | 1HP0 | 0.82 | |
CND | 5-BETA-D-RIBOFURANOSYLNICOTINAMIDE ADENINE DINUCLEOTIDE | A,B | 1ADB | 0.74 | |
FM1 | 2-HYDROXYMETHYL-5-(7-METHYLAMINO- 3H-PYRAZOLO[4,3-D]PYRIMIDIN-3-YL)- TETRAHYDRO-FURAN-3,4-DIOL | A,B,C,D,E,F | 1K9S | 0.86 | |
ONA | A,C | 2GVZ | 0.75 | ||
SND | THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B,C,D | 1IHX | 0.73 | |
SND | THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B,C | 1PTJ | 0.73 | |
NHV | (5R,6R,7S,8R)-6,7,8-trihydroxy- 5-(hydroxymethyl)-2-[(phenylamino)methyl]- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2VOT | 0.77 | |
XAE | 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-3H-IMIDAZO[4,5- G]QUINAZOLIN-8-AMINE | A,B | 2ICZ | 0.74 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 2ALY | 0.72 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 1VBM | 0.72 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 1VBN | 0.72 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 2PID | 0.72 | |
JMQ | (2R,3R,4S)-2-(hydroxymethyl)-1- [(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin- 7-yl)methyl]pyrrolidine-3,4-diol | A,B | 3EPW | 0.76 | |
PAD | 5-BETA-D-RIBOFURANOSYLPICOLINAMIDE ADENINE- DINUCLEOTIDE | A | 1A72 | 0.81 | |
PAD | 5-BETA-D-RIBOFURANOSYLPICOLINAMIDE ADENINE- DINUCLEOTIDE | A,B | 1ADC | 0.81 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,C,D,E,F | 3E8C | 0.72 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E88 | 0.72 | |
WSA | 5'-O-[(L-TRYPTOPHYLAMINO)SULFONYL]ADENOSINE | A,B,C,D | 2YY5 | 0.73 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,E,I,L,P | 3E8E | 0.72 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E8D | 0.72 | |
FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A,B | 2IY5 | 0.76 | |
FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A | 1B7Y | 0.76 | |
GDV | (5R,6R,7R,8S)-8-(ACETYLAMINO)-6,7- DIHYDROXY-5-(HYDROXYMETHYL)-N-PHENYL- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDINE-2-CARBOXAMIDE | A | 2J47 | 0.71 | |
ABR | (R)-(N-PHENYL-2-HYDROXY-ETHYL)- 2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE | A | 1K5E | 0.79 | |
DF2 | (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7- DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN- 4-YLIDENE]AMINO}PROPANE-1,2-DIOL | A | 2BRO | 0.7 | |
FA5 | ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE] | A | 3CMQ | 0.72 | |
FA5 | ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE] | A,B | 1JJC | 0.72 | |
3AA | 3-AMINOPYRIDINE-ADENINE DINUCLEOTIDE PHOSPHATE | A,B,E,F | 1F6M | 0.76 | |
RMB | N1-(5'-PHOSPHO-ALPHA-RIBOSYL)-5- METHYLBENZIMIDAZOLE | A | 1JHO | 0.73 | |
IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A | 1X39 | 0.76 | |
IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A,B | 2J7C | 0.76 | |
3DD | (2R,3R)-4-(4-AMINO-1H-IMIDAZO[4,5- C]PYRIDIN-1-YL)-2,3-DIHYDROXYBUTANOIC ACID | A,B,C,D,E,F, G,H | 2H5L | 0.73 | |
N20 | 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE | A,B,C,D | 1OI9 | 0.74 | |
RBZ | ALPHA-RIBAZOLE-5'-PHOSPHATE | A | 1D0V | 0.73 | |
RBZ | ALPHA-RIBAZOLE-5'-PHOSPHATE | A | 1L4E | 0.73 | |
121 | 2-(3-HYDROXY-PYRIDIN-2-YL)-1H-BENZOIMIDAZOLE- 5-CARBOXAMIDINE | H,I,L | 1GHY | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KQO | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H29 | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1NUQ | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1WXG | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KAQ | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1EE1 | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D | 3E27 | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1XQD | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H2A | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1IFX | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1XNG | 0.71 | |
V12 | 5'-[(1H-BENZIMIDAZOL-2-YLACETYL)AMINO]- 5'-DEOXYCYTIDINE | A,B | 2V2V | 0.75 | |
FCP | (2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H00 | 0.7 | |
3GO | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- (quinolin-6-ylmethylamino)purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZM | 0.77 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A | 1J1S | 0.84 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A,B,C,D,E,F | 1T8S | 0.84 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A | 1FMP | 0.84 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A | 1AHB | 0.84 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A,B | 1PAG | 0.84 | |
NDA | 3-AMINOMETHYL-PYRIDINIUM-ADENINE- DINUCLEOTIDE | A,B,C,D | 1EBU | 0.74 | |
FAP | (2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H00 | 0.7 | |
223 | (3R,4R)-1-[(4-AMINO-5H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)METHYL]-4-(HYDROXYMETHYL)PYRROLIDIN- 3-OL | A,B,C,D,E,F | 2ISC | 0.75 | |
AM0 | N-phenyl-1-{4-[(3,4,5-trimethoxyphenyl)amino]- 1,3,5-triazin-2-yl}-1H-benzimidazol- 2-amine | A | 3BYM | 0.7 | |
ANZ | A | 2V0C | 0.72 | ||
ANZ | A,B,D,F | 2V0G | 0.72 |